WO2012060678A3 - Vacunas novedosas contra el virus de la influencia pandémica a/h1n1 - Google Patents
Vacunas novedosas contra el virus de la influencia pandémica a/h1n1 Download PDFInfo
- Publication number
- WO2012060678A3 WO2012060678A3 PCT/MX2011/000132 MX2011000132W WO2012060678A3 WO 2012060678 A3 WO2012060678 A3 WO 2012060678A3 MX 2011000132 W MX2011000132 W MX 2011000132W WO 2012060678 A3 WO2012060678 A3 WO 2012060678A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- vaccines against
- flu virus
- virus
- novel vaccines
- pandemic flu
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/11—Orthomyxoviridae, e.g. influenza virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16171—Demonstrated in vivo effect
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA201300525A EA201300525A1 (ru) | 2010-11-02 | 2011-11-01 | Новые вакцины против пандемичного вируса гриппа a/h1n1 |
EP11838278.7A EP2650362A4 (en) | 2010-11-02 | 2011-11-01 | NEW VACCINES AGAINST PANDEMIC INFLUENZA A / H1N1 VIRUS |
CA2826234A CA2826234A1 (en) | 2010-11-02 | 2011-11-01 | Novel vaccines against the a/h1n1 pandemic flu virus |
BR112013010830A BR112013010830A2 (pt) | 2010-11-02 | 2011-11-01 | vacina inovadoras contra o vírus da influenza pandêmica a/h1n1 |
CN2011800639058A CN103328629A (zh) | 2010-11-02 | 2011-11-01 | 针对大流行性甲型流感病毒h1n1的新型疫苗 |
JP2013537626A JP2014511119A (ja) | 2010-11-02 | 2011-11-01 | H1n1亜型インフルエンザパンデミックウイルスに対する新型ワクチン |
KR1020137014167A KR20130140050A (ko) | 2010-11-02 | 2011-11-01 | A/h1n1 범유행 인플루엔자 바이러스에 대한 신규한 백신 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40930310P | 2010-11-02 | 2010-11-02 | |
US61/409,303 | 2010-11-02 | ||
MX2011011561A MX2011011561A (es) | 2011-10-31 | 2011-10-31 | Vacunas novedosas contra el virus de la influenza pandemica a/h1n1. |
MXMX/A/2011/011561 | 2011-10-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012060678A2 WO2012060678A2 (es) | 2012-05-10 |
WO2012060678A3 true WO2012060678A3 (es) | 2012-07-19 |
Family
ID=48537726
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/MX2011/000132 WO2012060678A2 (es) | 2010-11-02 | 2011-11-01 | Vacunas novedosas contra el virus de la influencia pandémica a/h1n1 |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP2650362A4 (es) |
JP (1) | JP2014511119A (es) |
KR (1) | KR20130140050A (es) |
CN (1) | CN103328629A (es) |
AP (1) | AP2013006835A0 (es) |
BR (1) | BR112013010830A2 (es) |
CA (1) | CA2826234A1 (es) |
EA (1) | EA201300525A1 (es) |
WO (1) | WO2012060678A2 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3445398A4 (en) * | 2016-04-18 | 2020-04-01 | Emerging Viral Vaccine (HK) Limited | LIVE ATTENUATED VACCINE WITHOUT VIRULENCE FACTOR AND SUITABLE FOR COLD SUITABLE FOR MUCOSAL ADMINISTRATION |
AU2018388102A1 (en) * | 2017-12-21 | 2020-07-16 | Green Biomed, Inc. | Cross-immunizing antigen vaccine and method for preparation thereof |
WO2020061443A2 (en) * | 2018-09-21 | 2020-03-26 | Board Of Regents Of The University Of Nebraska | Methods of making and using universal centralized influenza vaccine genes |
KR102218980B1 (ko) * | 2019-09-18 | 2021-02-23 | 한국생명공학연구원 | 오셀타미비르 내성 인플루엔자 바이러스에 대한 항체 |
WO2022055243A1 (ko) * | 2020-09-08 | 2022-03-17 | 주식회사 노블젠 | 인플루엔자 a 바이러스에 대한 항바이러스용 조성물 |
CN112063726A (zh) * | 2020-09-21 | 2020-12-11 | 杭州市疾病预防控制中心 | 一种用于检测奥司他韦耐药突变的引物、探针及检测方法 |
CN113151408A (zh) * | 2021-05-24 | 2021-07-23 | 厦门健康工程与创新研究院 | 一种等温环介导扩增方法及其应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2052699T3 (es) * | 1987-02-18 | 1994-07-16 | British Tech Group | Vacuna contra la gripe. |
ES2201184T3 (es) * | 1995-04-28 | 2004-03-16 | Protein Sciences Corporation | Vacunas virales mejoradas. |
US20070184526A1 (en) * | 2003-07-11 | 2007-08-09 | Gale Smith | Functional influenza virus like particles (VLPs) |
ES2338382T3 (es) * | 2006-03-22 | 2010-05-06 | Solvay Biologicals B.V. | Vacuna intranasal antigripal basada en virosomas. |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2454266T3 (es) * | 2004-05-25 | 2014-04-10 | Medimmune, Llc | Variantes de la hemaglutinina y la neuraminidasa de influenza |
WO2012061239A2 (en) * | 2010-11-02 | 2012-05-10 | Opko Pharmaceuticals, Llc | Novel vaccines against pandemic influenza virus a/h1n1 |
-
2011
- 2011-11-01 WO PCT/MX2011/000132 patent/WO2012060678A2/es active Application Filing
- 2011-11-01 JP JP2013537626A patent/JP2014511119A/ja active Pending
- 2011-11-01 EP EP11838278.7A patent/EP2650362A4/en not_active Withdrawn
- 2011-11-01 CA CA2826234A patent/CA2826234A1/en not_active Abandoned
- 2011-11-01 KR KR1020137014167A patent/KR20130140050A/ko not_active Application Discontinuation
- 2011-11-01 BR BR112013010830A patent/BR112013010830A2/pt not_active Application Discontinuation
- 2011-11-01 EA EA201300525A patent/EA201300525A1/ru unknown
- 2011-11-01 CN CN2011800639058A patent/CN103328629A/zh active Pending
- 2011-11-01 AP AP2013006835A patent/AP2013006835A0/xx unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2052699T3 (es) * | 1987-02-18 | 1994-07-16 | British Tech Group | Vacuna contra la gripe. |
ES2201184T3 (es) * | 1995-04-28 | 2004-03-16 | Protein Sciences Corporation | Vacunas virales mejoradas. |
US20070184526A1 (en) * | 2003-07-11 | 2007-08-09 | Gale Smith | Functional influenza virus like particles (VLPs) |
ES2338382T3 (es) * | 2006-03-22 | 2010-05-06 | Solvay Biologicals B.V. | Vacuna intranasal antigripal basada en virosomas. |
Non-Patent Citations (1)
Title |
---|
MARTINEZ R. ET AL.: "Influenza. Vacunas clasicas y novedosas a las puertas of otra pandemia.", VACCIMONITOR., vol. 15, no. 2, 2006, pages 22 - 29, XP055107941 * |
Also Published As
Publication number | Publication date |
---|---|
EP2650362A9 (en) | 2014-04-09 |
EP2650362A4 (en) | 2014-10-01 |
EA201300525A1 (ru) | 2014-02-28 |
EP2650362A2 (en) | 2013-10-16 |
WO2012060678A2 (es) | 2012-05-10 |
CA2826234A1 (en) | 2012-05-10 |
JP2014511119A (ja) | 2014-05-08 |
BR112013010830A2 (pt) | 2017-12-12 |
CN103328629A (zh) | 2013-09-25 |
KR20130140050A (ko) | 2013-12-23 |
AP2013006835A0 (en) | 2013-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012060678A3 (es) | Vacunas novedosas contra el virus de la influencia pandémica a/h1n1 | |
WO2010077986A3 (en) | Production of influenza vaccines | |
NZ627796A (en) | Influenza virus vaccines and uses thereof | |
IL231547B (en) | Polypeptide of the chimeric hemagglutinin (ha) from an influenza virus, an immune composition containing it and its uses | |
HK1199211A1 (en) | Influenza virus vaccines and uses thereof | |
WO2012024621A3 (en) | Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus hemagglutinin | |
HK1203524A1 (en) | Computationally optimized broadly reactive antigens for h3n2, h2n2, and b influenza viruses h3n2h2n2 b | |
HK1203522A1 (en) | Computationally optimized broadly reactive antigens for h5n1 and h1n1 influenza viruses h5n1 h1n1 | |
EA201290897A1 (ru) | Вакцины для пандемического гриппа | |
NZ606087A (en) | Influenza vaccine | |
WO2016100926A8 (en) | Synergistic co-administration of computationally optimized broadly reactive antigens for human and avian h5n1 influenza | |
MX363464B (es) | Vacunas contra influenza h5. | |
WO2012024283A3 (en) | Universal influenza a vaccines | |
EA201590860A1 (ru) | Варианты гемагглютинина и нейраминидазы вируса свиного гриппа | |
AU2015364253B2 (en) | Synergistic co-administration of computationally optimized broadly reactive antigens for H1N1 influenza | |
WO2012058493A3 (en) | Recombinant hemagglutinin protein of influenza virus and vaccine containing the same | |
MX343411B (es) | Variantes de hemaglutinina y neuraminidasa de influenza. | |
WO2012061239A3 (en) | Novel vaccines against pandemic influenza virus a/h1n1 | |
SG10201703245SA (en) | Fragments of the pa subunit of rna dependent rna polymerase from pandemic influenza virus a 2009 h1n1, and their use | |
MX2011011561A (es) | Vacunas novedosas contra el virus de la influenza pandemica a/h1n1. | |
WO2011138032A3 (en) | Universal influenza vaccines and methods for their generation | |
EP2195019A4 (en) | METHOD FOR TRIGGERING AN IMMUNE RESPONSE AGAINST THE PANDEMIC INFLUENZA VIRUS | |
MY180091A (en) | Vaccines and vaccine compositions, and methods for the manufacture thereof | |
PL406631A1 (pl) | Antygen, szczepionka przeciwko grypie, układ do wytwarzania szczepionki, sposób wytwarzania antygenu oraz zastosowanie antygenu określonego powyżej do wytwarzania szczepionki przeciwko grypie | |
WO2008115785A3 (en) | Multivalent avian influenza vaccines and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENP | Entry into the national phase |
Ref document number: 2013537626 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 20137014167 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13133991 Country of ref document: CO Ref document number: 201300525 Country of ref document: EA Ref document number: CR2013-000257 Country of ref document: CR |
|
REEP | Request for entry into the european phase |
Ref document number: 2011838278 Country of ref document: EP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11838278 Country of ref document: EP Kind code of ref document: A2 |
|
ENP | Entry into the national phase |
Ref document number: 2826234 Country of ref document: CA |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112013010830 Country of ref document: BR |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01E Ref document number: 112013010830 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112013010830 Country of ref document: BR Kind code of ref document: A2 Effective date: 20130502 |